104,403 Shares in Varex Imaging Co. (NASDAQ:VREX) Purchased by Susquehanna Fundamental Investments LLC

Susquehanna Fundamental Investments LLC acquired a new position in shares of Varex Imaging Co. (NASDAQ:VREX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 104,403 shares of the company's stock, valued at approximately $1,523,000. Susquehanna Fundamental Investments LLC owned about 0.25% of Varex Imaging at the end of the most recent quarter.

Several other large investors have also modified their holdings of the stock. Wealthfront Advisers LLC acquired a new stake in Varex Imaging during the 4th quarter worth $18,900,000. Boston Partners purchased a new position in shares of Varex Imaging during the fourth quarter worth about $8,718,000. Russell Investments Group Ltd. increased its position in shares of Varex Imaging by 510.7% during the fourth quarter. Russell Investments Group Ltd. now owns 471,612 shares of the company's stock worth $6,881,000 after purchasing an additional 394,381 shares in the last quarter. Royce & Associates LP lifted its holdings in shares of Varex Imaging by 70.4% in the 4th quarter. Royce & Associates LP now owns 746,770 shares of the company's stock valued at $10,895,000 after purchasing an additional 308,629 shares during the last quarter. Finally, LSV Asset Management lifted its holdings in shares of Varex Imaging by 826.3% in the 4th quarter. LSV Asset Management now owns 326,979 shares of the company's stock valued at $4,771,000 after purchasing an additional 291,679 shares during the last quarter.

Insider Activity at Varex Imaging

In related news, SVP Kimberley E. Honeysett sold 4,007 shares of the firm's stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $12.81, for a total value of $51,329.67. Following the completion of the sale, the senior vice president now owns 4,002 shares in the company, valued at $51,265.62. This trade represents a 50.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Sunny Sanyal sold 8,749 shares of the business's stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $11.24, for a total value of $98,338.76. Following the transaction, the chief executive officer now owns 190,193 shares in the company, valued at $2,137,769.32. The trade was a 4.40 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by insiders.

Varex Imaging Stock Performance

Shares of VREX traded up $0.32 during mid-day trading on Friday, hitting $8.71. 326,687 shares of the company's stock were exchanged, compared to its average volume of 571,298. The company has a current ratio of 4.36, a quick ratio of 2.50 and a debt-to-equity ratio of 1.02. Varex Imaging Co. has a fifty-two week low of $6.97 and a fifty-two week high of $16.93. The business's 50 day moving average is $10.35 and its two-hundred day moving average is $12.86. The firm has a market capitalization of $358.85 million, a P/E ratio of -7.44 and a beta of 0.62.

Varex Imaging (NASDAQ:VREX - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.07 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. On average, equities analysts expect that Varex Imaging Co. will post 0.53 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. StockNews.com upgraded Varex Imaging from a "hold" rating to a "buy" rating in a research note on Friday, February 7th. Oppenheimer lowered their target price on shares of Varex Imaging from $30.00 to $23.00 and set an "outperform" rating on the stock in a research report on Friday, February 7th. Finally, B. Riley reaffirmed a "buy" rating and issued a $22.00 target price (up from $21.00) on shares of Varex Imaging in a report on Friday, February 7th.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.